A detailed history of Independence Bank Of Kentucky transactions in Astrazeneca PLC stock. As of the latest transaction made, Independence Bank Of Kentucky holds 1,606 shares of AZN stock, worth $103,490. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,606
Previous 1,515 6.01%
Holding current value
$103,490
Previous $118,000 5.93%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$76.67 - $87.62 $6,976 - $7,973
91 Added 6.01%
1,606 $125,000
Q2 2024

Jul 25, 2024

BUY
$66.81 - $80.83 $66,810 - $80,830
1,000 Added 194.17%
1,515 $118,000
Q3 2022

Oct 06, 2022

SELL
$53.02 - $135.75 $7,687 - $19,683
-145 Reduced 21.97%
515 $28,000
Q2 2021

Jul 23, 2021

BUY
$48.42 - $60.18 $7,989 - $9,929
165 Added 33.33%
660 $40,000
Q3 2019

Oct 21, 2019

BUY
$40.12 - $45.47 $19,859 - $22,507
495 New
495 $22,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Independence Bank Of Kentucky Portfolio

Follow Independence Bank Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independence Bank Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Independence Bank Of Kentucky with notifications on news.